This inventor holds 1 USPTO granted patent. Top assignee: Pliva, Farmaceutska, Kemijska, Prehrambena I Kozmeticka Industrija, Dionicko Drustvo. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Marina Orešhaeck Overšić: Innovator in Pharmaceutical Chemistry
Introduction
Marina Orešhaeck Overšić is a notable inventor based in Sesvete, Croatia. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on torasemide. Her dedication to research and development has led to advancements that benefit the pharmaceutical industry.
Latest Patents
Marina holds a patent for the "Crystal modification of torasemide." This invention involves the characterization of a new crystal modification III of torasemide. The process for preparing this modification includes controlled acidifying of alkaline solutions of torasemide with inorganic or organic acids, with or without the addition of a crystal seed. This new crystal modification III serves as a raw material for the preparation of the crystal modification I of torasemide and its pharmaceutically acceptable salts. Additionally, it is utilized in pharmaceutical forms containing this innovative modification.
Career Highlights
Marina is associated with Pliva, a prominent pharmaceutical, chemical, food, and cosmetic industry company. Her work at Pliva has allowed her to engage in cutting-edge research and development, contributing to the advancement of pharmaceutical products.
Collaborations
Throughout her career, Marina has collaborated with esteemed colleagues such as Darko Filić and Miljenko Dumić. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Marina Orešhaeck Overšić exemplifies the spirit of innovation in pharmaceutical chemistry. Her contributions, particularly in the development of torasemide modifications, highlight her role as a key inventor in the industry. Her work continues to influence the pharmaceutical landscape positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile